- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Akums Drugs and Pharmaceuticals has announced a board meeting to discuss key resolutions concerning the ratification and amendment of its Employee Stock Option Scheme (ESOP) 2022. Among the highlights, the board seeks member approval for extending plan benefits to subsidiary employees and increasing the vesting period from three to five years. This initiative aims to enhance employee retention and motivation, ultimately aligning their interests with company growth. Investors may view this move positively as it reflects management's commitment to employee engagement, though attention should be paid to potential dilution of shares from the option grants.
All announcements from Akums Drugs and Pharmaceuticals Limited